Connect with us

Bloomberg Technology

Novavax Sending 200 Million Vaccines to EU

Aug.05 — Novavax CEO Stanley Erck discusses his biotech company’s deal to send 200 million doses of the Covid vaccine to the EU even though the drug is not approved for use yet. He speaks with Emily Chang on “Bloomberg Technology.”

Published

on

Aug.05 — Novavax CEO Stanley Erck discusses his biotech company’s deal to send 200 million doses of the Covid vaccine to the EU even though the drug is not approved for use yet. He speaks with Emily Chang on “Bloomberg Technology.”

Continue Reading
Advertisement
3 Comments

3 Comments

  1. thejeffinvade

    August 5, 2021 at 11:30 pm

    recombinant vaccine isn’t new. They are late to the game.

  2. mrPmj00

    August 5, 2021 at 11:50 pm

    — AMAZON:
    Yep, I bought a ton on the dip.

    Amazon invested $14 billion in the last quarter alone, the same as it spent in 6 months before that. It is a do not sell stock.

    …With the Delta virus coming at full speed ahead, pandemic sales will make a comeback.

    Amazon is investing so much money, that no competitor will ever be able to catch up.

    My strategy is if Amazon keeps going down, I buy more to average cost down..
    I buy using money on the sideline, then I sell other stocks that are up, then I sell other stocks that have lost less than Amazon’s -7.5%. Most stocks that pop or

    drop hard usually recover 50% soon after.
    Amazon’s not going anywhere so I know that eventually it will come back.
    Fidelity considers Amazon as a large growth company (probably because as big as it is, it still only has 7% of the retail market)

    Get on board or be runover, it’s up to you.

  3. mrPmj00

    August 5, 2021 at 11:50 pm

    …Lockdown! Lockdown! Lockdown! Lockdown! Lockdown! Lockdown! Lockdown! Lockdown!
    CDC said the Delta variant is 1000 times more contagious than before.

Leave a Reply

Your email address will not be published. Required fields are marked *

Bloomberg Technology

Halozyme CEO: Evotec Is Poised for Growth

Halozyme CEO Helen Torley joins to discuss the company’s intended acquisition of biotech company Evotech. She speaks with Caroline Hyde on “Bloomberg Technology.” ——– Like this video? Subscribe to Bloomberg Technology on YouTube:   Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:   Get the latest in tech…

Published

on

Halozyme CEO Helen Torley joins to discuss the company’s intended acquisition of biotech company Evotech. She speaks with Caroline Hyde on “Bloomberg Technology.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:

 
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:
 
Listen to the daily Bloomberg Technology podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Bloomberg Technology

Trump’s Future for AI

Doug Calidas of the Harvard Belfer Center says Donald Trump’s previous administration was encouraging to the AI sector and hopes it will continue as they ramp up US innovations. He speaks with Caroline Hyde on “Bloomberg Technology.” ——– Like this video? Subscribe to Bloomberg Technology on YouTube:   Watch the latest full episodes of “Bloomberg…

Published

on

Doug Calidas of the Harvard Belfer Center says Donald Trump’s previous administration was encouraging to the AI sector and hopes it will continue as they ramp up US innovations. He speaks with Caroline Hyde on “Bloomberg Technology.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:

 
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:
 
Listen to the daily Bloomberg Technology podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Bloomberg Technology

Apple’s Tim Cook May Have Sighed Relief on a Trump Win

Apple’s China reliance may prove to be a vulnerable target for the tech giant under President-elect Donald Trump. Bloomberg’s Mark Gurman says CEO Tim Cook has some maneuvers that could alleviate those worries. He joins Caroline Hyde to discuss on “Bloomberg Technology.” ——– Like this video? Subscribe to Bloomberg Technology on YouTube:   Watch the…

Published

on

Apple’s China reliance may prove to be a vulnerable target for the tech giant under President-elect Donald Trump. Bloomberg’s Mark Gurman says CEO Tim Cook has some maneuvers that could alleviate those worries. He joins Caroline Hyde to discuss on “Bloomberg Technology.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:

 
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:
 
Listen to the daily Bloomberg Technology podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Trending